| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2009 | US20090203748 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 08/13/2009 | US20090203747 Novel chemical compounds and the uses thereof as a medicine |
| 08/13/2009 | US20090203745 Heterocyclic compounds for the inhibition of integrins and use thereof |
| 08/13/2009 | US20090203744 Novel pyridine derivatives |
| 08/13/2009 | US20090203743 Small molecule entry inhibitors |
| 08/13/2009 | US20090203742 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 08/13/2009 | US20090203741 Crystals of benzoxadiazole derivative |
| 08/13/2009 | US20090203740 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203738 Pharmaceutical Composition for Treating Bulimia and Depression Arising from Bulimia |
| 08/13/2009 | US20090203737 Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors |
| 08/13/2009 | US20090203736 Piperidine sulphonamide derivatives |
| 08/13/2009 | US20090203735 Treatments for neuropathy |
| 08/13/2009 | US20090203734 F1f0-atpase inhibitors and related methods |
| 08/13/2009 | US20090203733 Pharmaceutical composition |
| 08/13/2009 | US20090203732 Thiazolones for Use as P13 Kinase Inhibitors |
| 08/13/2009 | US20090203731 Treatment of depression and other affective disorders |
| 08/13/2009 | US20090203730 Bicyclic ppat inhibitors as antibacterial agents |
| 08/13/2009 | US20090203729 Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof |
| 08/13/2009 | US20090203728 Naphthalamide derivatives having antiproliferative activity |
| 08/13/2009 | US20090203727 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
| 08/13/2009 | US20090203726 Substituted tetrahydroquinolines as antibacterial agents |
| 08/13/2009 | US20090203725 Androgen Receptor Modulator Compounds and Methods |
| 08/13/2009 | US20090203724 Solid and crystalline dutasteride and processes for preparation thereof |
| 08/13/2009 | US20090203723 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 08/13/2009 | US20090203722 Novel compositions and methods for enhancing potency or reducing adverse side effects of opiold agonists |
| 08/13/2009 | US20090203721 Use of siramesine in the treatment of cancer |
| 08/13/2009 | US20090203720 Methods for inhibiting cell growth |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203718 Cancer treatment method |
| 08/13/2009 | US20090203717 Fused heterocyclic compound |
| 08/13/2009 | US20090203716 Pyrimidine low molecular weight ligands for modulating hormone receptors |
| 08/13/2009 | US20090203715 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 08/13/2009 | US20090203714 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 08/13/2009 | US20090203713 Hedgehog pathway antagonists to treat disease |
| 08/13/2009 | US20090203712 Urea Derivative |
| 08/13/2009 | US20090203711 Inhibitors of P38 Map Kinase |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203709 Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
| 08/13/2009 | US20090203708 Novel substituted-1-h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 08/13/2009 | US20090203707 Methods for treating pain |
| 08/13/2009 | US20090203706 Lysine-based polymeric linkers |
| 08/13/2009 | US20090203705 Spiro Compounds As NPY Y5 Receptor Antagonists |
| 08/13/2009 | US20090203704 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative |
| 08/13/2009 | US20090203703 Thienopyrimidine Derivatives |
| 08/13/2009 | US20090203702 INHIBITORS OF p38 |
| 08/13/2009 | US20090203701 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
| 08/13/2009 | US20090203699 Aminomethylpyridine derivatives, method for preparing same and therapeutic use thereof |
| 08/13/2009 | US20090203698 Compounds for Enzyme Inhibition |
| 08/13/2009 | US20090203697 Heterocyclic type cinnamide derivative |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203695 Compounds IV |
| 08/13/2009 | US20090203694 Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/13/2009 | US20090203693 Therapeutic agent for liver fibrosis |
| 08/13/2009 | US20090203692 Novel chemical compounds |
| 08/13/2009 | US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases |
| 08/13/2009 | US20090203690 5-substituted indazoles as kinase inhibitors |
| 08/13/2009 | US20090203689 Abca-1 elevating compounds and methods |
| 08/13/2009 | US20090203688 Heterocyclic compounds |
| 08/13/2009 | US20090203687 Fused ring heterocycle kinase modulators |
| 08/13/2009 | US20090203686 Aminoalkyl-Amidomethyl-Substituted 2-(4-Sulphonylamino)- 3-Hydroxy-3,4-Dihydro-2H-Chroman-6-yl Derivatives |
| 08/13/2009 | US20090203685 Anti-proliferative compounds from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 08/13/2009 | US20090203684 Tyrosine kinase inhibitors |
| 08/13/2009 | US20090203683 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
| 08/13/2009 | US20090203682 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological Disorders |
| 08/13/2009 | US20090203681 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/13/2009 | US20090203680 In vivo studies of crystalline forms of meloxicam |
| 08/13/2009 | US20090203679 Galenical formulations of organic compounds |
| 08/13/2009 | US20090203678 Pharmaceutical compositions for the treatment of protozoan parasitic diseases |
| 08/13/2009 | US20090203677 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | US20090203676 G-protein Coupled Receptor Agonists |
| 08/13/2009 | US20090203675 Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses |
| 08/13/2009 | US20090203673 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
| 08/13/2009 | US20090203672 Substituted Sulfonamide Compounds |
| 08/13/2009 | US20090203671 Method of treating cancer |
| 08/13/2009 | US20090203670 Combination Antidepressants Wafer |
| 08/13/2009 | US20090203669 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/13/2009 | US20090203667 Pentadienamide derivatives |
| 08/13/2009 | US20090203666 Compounds and compositions as hedgehog pathway modulators |
| 08/13/2009 | US20090203665 Heterocyclic-substituted phenyl methanones |
| 08/13/2009 | US20090203664 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- diazabicyclo[3.2.0]heptane |
| 08/13/2009 | US20090203663 Chemical compounds |
| 08/13/2009 | US20090203662 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
| 08/13/2009 | US20090203661 Betulinic acid, derivatives and analogs thereof and uses therefor |
| 08/13/2009 | US20090203660 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 08/13/2009 | US20090203659 Method of enhancing hair growth |
| 08/13/2009 | US20090203658 Neuroactive steroid compositions and methods of use therefor |
| 08/13/2009 | US20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | US20090203656 Method for the Reduction of Dangerous Blood Sugar Levels |
| 08/13/2009 | US20090203655 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 08/13/2009 | US20090203654 3-(Hydroxy-),4-(2-(2-(amino-),7-(hydroxy-)naphth-1-yl)ethylene-benzoic acid; activities like Heparin Binding Epidermal Growth Factorrelease from keratinocytes, antiproliferative agents; skin disorderswithout irritation side effects like interleukin 8 release andterminal differentiation inhibition |
| 08/13/2009 | US20090203653 Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors |
| 08/13/2009 | US20090203652 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 08/13/2009 | US20090203651 Use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome |
| 08/13/2009 | US20090203650 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 08/13/2009 | US20090203649 Dermatological anti-wrinkle agent |
| 08/13/2009 | US20090203648 Modified phosphocalcic compound, injectable composition containing same |
| 08/13/2009 | US20090203646 Use of sodium narcistatin for reducing internal adhesions and fibrosis |
| 08/13/2009 | US20090203644 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |